Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort

American Journal of Gastroenterology

Volumn 106, Issue 7, 2011, Pages 1340-1350

  Ruder, Elizabeth H ^a   Laiyemo, Adeyinka O ^b   Graubard, Barry I ^a   Hollenbeck, Albert R ^c   Schatzkin, Arthur ^a   Cross, Amanda J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c AARP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

ADULT; AGED; ARTICLE; CANCER RISK; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESCENDING COLON; FAMILY HISTORY; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM;

ADENOCARCINOMA; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FAMILY HEALTH; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 79960059582     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.38     Document Type: Article

References (43)

1. Mantovani A, Allavena P, Sica A et al. Cancer-related inflammation. Nature 2008; 454: 436-44.
2. Danese S, Mantovani A. Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer. Oncogene 2010; 29: 3313-23.
3. Dube C, Rostom A, Lewin G et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the US Preventive Services Task Force. Ann Intern Med 2007; 146: 365-75. (Pubitemid 351650597)
4. Rostom A, Dube C, Lewin G e t al. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the US Preventive Services Task Force. Ann Intern Med 2007; 146: 376-89. (Pubitemid 351650598)
5. Barnes CJ, Cameron IL, Hardman WE e t al. Non-steroidol antiinflammatory drug Effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis. Br J Cancer 1998; 77: 573-80. (Pubitemid 28059464)
6. Tsujii M, Kawano S, Tsuji S et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 705-16. (Pubitemid 28257578)
7. Mahipal A, Anderson KE, Limburg PJ et al. Nonsteroidal antiinflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 2006; 15: 1785-90. (Pubitemid 44664249)
8. Smalley W, Ray WA, Daugherty J e t al. Use of nonsteroidal antiinflammatory drugs and incidence of colorectal cancer: a populationbased study. Arch Intern Med 1999; 159: 161-6. (Pubitemid 29055104)
9. Chan AT, Giovannucci EL, Meyerhardt JA e t al. Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology 2008; 134: 21-8. (Pubitemid 350309311)
10. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990; 113: 779-88. (Pubitemid 20369667)
11. Gervaz P, Bucher P, Morel P. Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol 2004; 88: 261-6. (Pubitemid 39601269)
12. Potter JD, Hunter DJ. Colorectal cancer. In: Adami H.e.a (ed) Textbook of Cancer Epidemiology. Oxford: New York, 2008 pp 279-81.
13. Jemal A, Siegel R, Xu J et al. Cancer Statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
14. Schatzkin A, Subar AF, Thompson FE et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001; 154: 1119-25. (Pubitemid 33140635)
15. Michaud DS, Midthune D, Hermansen S et al. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Registry Manag 2005; 32: 70-5.
16. WHO. International Classification of Diseases for Oncology, 3rd edn Geneva, Switzerland, 2000.
17. Surveillance and End results (SEER) Fast Stats [cited 2 November 2010]. Available from http://seer.cancer.gov/faststats/.
18. Chan AT, Giovannucci EL, Meyerhardt JA e t al. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 2005; 294: 914-23. (Pubitemid 41215460)
19. Sorensen HT, Friis S, Norgard B et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 2003; 88: 1687-92. (Pubitemid 36760410)
20. Giovannucci E, Egan KM, Hunter DJ et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995; 333: 609-14.
21. Giovannucci E, Rimm EB, Stampfer MJ et al. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994; 121: 241-6.
22. Paganini-Hill A. Aspirin and colorectal cancer: the Leisure World cohort revisited. Prev Med 1995; 24: 113-5.
23. Sturmer T, Glynn RJ, Lee IM et al. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians ' Health Study. Ann Intern Med 1998; 128: 713-20. (Pubitemid 28204862)
24. Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007; 369: 1603-13. (Pubitemid 46710123)
25. Friis S, Sorensen HT, McLaughlin JK et al. A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer 2003; 88: 684-8. (Pubitemid 36411444)
26. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994; 5: 138-46. (Pubitemid 24073387)
27. Nelson RL, Dollear T, Freels S et al. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 1997; 80: 193-7. (Pubitemid 27282310)
28. Bonithon-Kopp C, Benhamiche AM. Are there several colorectal cancers? Epidemiological data. Eur J Cancer Prev 1999; 8 (Suppl 1): S3-S12. (Pubitemid 30185691)
29. Gonzalez EC, Roetzheim RG, Ferrante JM et al. Predictors of proximal vs. distal colorectal cancers. Dis Colon Rectum 2001; 44: 251-8. (Pubitemid 32173775)
30. Ward R, Meagher A, Tomlinson I et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 2001; 48: 821-9. (Pubitemid 32476985)
31. Dimberg J, Samuelsson A, Hugander A. Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut 1999; 45: 730-2. (Pubitemid 29492147)
32. Wiese FW, Thompson PA, Warneke J et al. Variation in cyclooxygenase expression levels within the colorectum. Mol Carcinog 2003; 37: 25-31. (Pubitemid 36535125)
33. Rothwell PM, Wilson M, Elwin CE et al. Long-term Effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010; 376: 1741-50.
34. Coogan PF, Rosenberg L, Louik C et al. NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease. Cancer Causes Control 2000; 11: 249-55. (Pubitemid 30182142)
35. Steinbach G, Lynch PM, Phillips RK et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000; 342: 1946-52. (Pubitemid 30419089)
36. Giardiello FM, Hamilton SR, Krush AJ et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328: 1313-6. (Pubitemid 23131373)
37. Burn J, Bishop DT, Mecklin JP e t al. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med 2008; 359: 2567-78.
38. Collet JP, Sharpe C, Belzile E et al. Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: Effects of dosage and timing. Br J Cancer 1999; 81: 62-8. (Pubitemid 29415492)
39. Garcia-Rodriguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 2001; 12: 88-93. (Pubitemid 32006467)
40. Reeves MJ, Newcomb PA, Trentham-Dietz A et al. Nonsteroidal antiinflammatory drug use and protection against colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 1996; 5: 955-60. (Pubitemid 26415866)
41. Slattery ML, Samowitz W, Hoff man M et al. Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway. Cancer Epidemiol Biomarkers Prev 2004; 13: 538-45. (Pubitemid 38737888)
42. Cook NR, Lee IM, Gaziano JM et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005; 294: 47-55. (Pubitemid 41002838)
43. Gann PH, Manson JE, Glynn RJ et al. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 1993; 85: 1220-4. (Pubitemid 23223527)